Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir for HIV eradication in PBMCs
NCT01173510Phase 4Withdrawn
- Sponsor
- Community Research Initiative of New England
- Start
- Aug 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Community Research Initiative of New England. Planned start Aug 2010; status: withdrawn.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01173510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173510.